- Gregory Bolan is currently at Avondale Partners, LLC, a Nashville-based boutique investment banking and asset management firm, where he is a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services. It’s no surprise at all, given that his decade-plus-long career has been focused primarily on the healthcare and targeted middle market sectors. Greg has been working for years to hone his research and investment skills because that is what makes the difference and informs every investment decision he makes.
Contact
Browse > Home
/ The Career of Greg Bolan
October 16, 2016
The Career of Greg Bolan
These days, Greg Bolan can be found at Avondale Partners, LLC, a boutique investment banking and asset management firm in Nashville. There, he serves as a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services. His entire career has been focused primarily on the healthcare and targeted middle market sectors.
For about the last decade, Greg Bolan has been honing his skills as a gifted researcher in the financial field and that experience informs every investment decision he makes these days. His experience as a research analyst is stellar. Before Avondale, Greg was with with Sterne Agee as their Managing Director of Healthcare Equity Research. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies and he received a lot of recognition as a result, having been recognized by Starmine as a No. 1 Stock Picker for Life Science Tools & Services in 2014 and as the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. Greg also helped to build an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
Greg Bolan’s career experience also includes extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital, New York. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.
For about the last decade, Greg Bolan has been honing his skills as a gifted researcher in the financial field and that experience informs every investment decision he makes these days. His experience as a research analyst is stellar. Before Avondale, Greg was with with Sterne Agee as their Managing Director of Healthcare Equity Research. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies and he received a lot of recognition as a result, having been recognized by Starmine as a No. 1 Stock Picker for Life Science Tools & Services in 2014 and as the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. Greg also helped to build an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
Greg Bolan’s career experience also includes extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital, New York. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.